Ainos Q3 Revenue Jumps to $642,889, Net Loss Narrows 36%; $11M Convertible Notes Now Current
AIMD has more than doubled off its 52-week low of $0.434 on elevated volume (3.1× avg).
Summary
Ainos reported Q3 revenue of $642,889, mostly a one-time $600,000 license fee, and a narrower $1.89M net loss. The company also disclosed $660,916 of cash against $16.6M of current liabilities, including $11M of convertible notes now due within a year.
Key Events · Earnings and Guidance · AIMD
-
Q3 Revenue Boosted by One-Time License Fee
Revenue was $642,889 versus $2,167 a year earlier, but $600,000 of that was the initial VELDONA license fee recognized on completion of technology transfer.
-
Net Loss Narrows 36%
GAAP net loss fell to $1,886,074 from $2,931,702; non-GAAP adjusted net loss was $672,352 versus $1,376,705, and GAAP gross margin rose to 83.4% from 78.0%.
-
Liquidity Tight as $11M Notes Turn Current
Cash was $660,916 at September 30, 2026 against total current liabilities of $16,594,900, which now include $11,000,000 of convertible notes payable; management said discussions to address the 2027 notes have begun.
-
$9M AI Nose Order Is the Funding Lever
The follow-on agreement for 5,000 AI Nose systems calls for a $4.5 million initial payment within 60 days of signing, with the balance on delivery; the company also collected $950,000 in contractual payments after quarter-end.
Analysis · AIMD · Technology
The headline revenue growth is misleading: $642,889 is almost entirely the one-time $600,000 VELDONA license fee, so it overstates the underlying business. More important is the balance sheet, where cash of $660,916 stands against $16.6M of current liabilities, including $11M of convertible notes that have moved into current. Management says it has only begun discussions on the 2027 notes. The near-term funding lever is the $9M AI Nose follow-on order and its $4.5M initial payment due within 60 days — if that cash arrives, liquidity improves; if it slips, the company has very little cushion.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AIMD was trading at $1.32 on NASDAQ in the Technology sector, with a market capitalization of approximately $10.7M. The 52-week trading range was $0.43 to $3.88. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.